A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting products of unknown origin.
Several experts said the demand for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.
Service Reaction and Material Removal
According to TikTok, the platform has taken down violative material and banned associated keywords and query recommendations. The company said it was committed to maintaining the service safe and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, glowing testimonials and detailed guides for mixing or administering at home.
After minutes of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller sent an guidebook and promised shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.
Product Information and Costs
Inside these communities, posts show black plastic packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has already seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially serious health risks”.
